Aldeyra Therapeutics, Inc.
US ˙ NasdaqCM ˙ US01438T1060

SecurityALDX / Aldeyra Therapeutics, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership83,449 shares
Latest Disclosed Value $ 432,266
Group One Trading, L.p. ownership in ALDX / Aldeyra Therapeutics, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 83,449 shares of Aldeyra Therapeutics, Inc. (US:ALDX) valued at $432,266 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 113,584 shares of Aldeyra Therapeutics, Inc.. This represents a change in shares of -26.53% during the quarter. The current value of the position is $136,022 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (ALDX) in the form of stock options. The firm currently holds call options representing 180,400 of underlying shares valued at $934,472 USD and put options representing 128,400 of underlying shares valued at $665,112 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ALDX / Aldeyra Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 83,449 -30,135 -26.53 432 -27.03 0.0008
2025-11-12 2025-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 113,584 -19,403 -14.59 593 16.31 0.0010
2025-08-14 2025-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 132,987 -31,424 -19.11 509 -46.14 0.0011
2025-05-14 2025-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 164,411 -39,740 -19.47 945 -7.17 0.0027
2025-05-14 2024-12-31 13F/A-1 ALDEYRA THERAPEUTICS COM 01438T106 204,151 174,719 593.64 1,019 544.30 0.0023
2025-02-14 2024-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 204,151 174,719 1,019 0.0025
2024-11-14 2024-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 29,432 27,586 1,494.37 159 2,533.33 0.0005
2024-08-14 2024-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 1,846 -4,200 -69.47 6 -68.42 0.0000
2024-05-10 2024-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 6,046 -6,959 -53.51 20 -57.78 0.0001
2024-02-14 2023-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 13,005 -52,541 -80.16 46 -89.70 0.0001
2023-11-09 2023-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 65,546 65,546 438 0.0015
2023-08-09 2023-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 0 -100,909 -100.00 0 -100.00
2023-05-12 2023-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 100,909 86,292 590.35 1,002 892.08 0.0036
2023-02-09 2022-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 14,617 -11,296 -43.59 102 -26.81 0.0002
2022-11-09 2022-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 25,913 2,597 11.14 138 48.39 0.0003
2022-08-11 2022-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 23,316 -49,752 -68.09 93 -71.38 0.0001
2022-05-12 2022-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 73,068 -5,800 -7.35 325 3.17 0.0003
2022-02-11 2021-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 78,868 -2,453 -3.02 315 -55.88 0.0003
2021-11-12 2021-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 81,321 81,321 714 0.0008
2021-08-10 2021-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 0 -60,553 -100.00 0 -100.00
2021-05-12 2021-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 60,553 60,553 719 0.0011
2021-02-10 2020-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 0 -24,162 -100.00 0 -100.00
2020-11-12 2020-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 24,162 14,415 147.89 179 336.59 0.0006
2020-08-13 2020-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 9,747 2,645 37.24 41 127.78 0.0002
2020-05-13 2020-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 7,102 -4,073 -36.45 18 -72.31 0.0001
2020-02-10 2019-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 11,175 4,912 78.43 65 96.97 0.0004
2019-11-12 2019-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 6,263 -9,200 -59.50 33 -64.52 0.0003
2019-08-09 2019-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 15,463 -12,092 -43.88 93 -62.65 0.0008
2019-05-14 2019-03-31 13F/A-1 ALDEYRA THERAPEUTICS COM 01438T106 27,555 27,555 78.20 249 167.74 0.0028
2019-05-13 2019-03-31 13F ALDEYRA THERAPEUTICS COM 01438T106 27,555 27,555 249
2019-02-05 2018-12-31 13F ALDEYRA THERAPEUTICS COM 01438T106 0 -457 -100.00 0 -100.00
2018-11-08 2018-09-30 13F ALDEYRA THERAPEUTICS COM 01438T106 457 -243 -34.71 6 0.00 0.0000
2018-08-13 2018-06-30 13F ALDEYRA THERAPEUTICS COM 01438T106 700 700 6 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ALDEYRA THERAPEUTICS COM Call 180,400 -2.96 934 -3.71 n/a n/a n/a
2025-11-12 2025-09-30 13F ALDEYRA THERAPEUTICS COM Call 185,900 473.77 970 682.26 n/a n/a n/a
2025-08-14 2025-06-30 13F ALDEYRA THERAPEUTICS COM Call 32,400 -89.01 124 -92.68 n/a n/a n/a
2025-05-14 2025-03-31 13F ALDEYRA THERAPEUTICS COM Call 294,700 182.01 1,695 225.14 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ALDEYRA THERAPEUTICS COM Call 104,500 37.32 521 27.07 n/a n/a n/a
2025-02-14 2024-12-31 13F ALDEYRA THERAPEUTICS COM Call 104,500 521 n/a n/a n/a
2024-11-14 2024-09-30 13F ALDEYRA THERAPEUTICS COM Call 76,100 5.55 410 72.27 n/a n/a n/a
2024-08-14 2024-06-30 13F ALDEYRA THERAPEUTICS COM Call 72,100 29.68 239 31.49 n/a n/a n/a
2024-05-10 2024-03-31 13F ALDEYRA THERAPEUTICS COM Call 55,600 37.62 182 28.37 n/a n/a n/a
2024-02-14 2023-12-31 13F ALDEYRA THERAPEUTICS COM Call 40,400 228.46 142 71.95 n/a n/a n/a
2023-11-09 2023-09-30 13F ALDEYRA THERAPEUTICS COM Call 12,300 -54.10 82 -63.39 n/a n/a n/a
2023-08-09 2023-06-30 13F ALDEYRA THERAPEUTICS COM Call 26,800 87.41 225 58.87 n/a n/a n/a
2023-05-12 2023-03-31 13F ALDEYRA THERAPEUTICS COM Call 14,300 2.14 142 45.36 n/a n/a n/a
2023-02-09 2022-12-31 13F ALDEYRA THERAPEUTICS COM Call 14,000 -75.90 97 -68.71 n/a n/a n/a
2022-11-09 2022-09-30 13F ALDEYRA THERAPEUTICS COM Call 58,100 -66.88 310 -55.71 n/a n/a n/a
2022-08-11 2022-06-30 13F ALDEYRA THERAPEUTICS COM Call 175,400 540.15 700 473.77 n/a n/a n/a
2022-05-12 2022-03-31 13F ALDEYRA THERAPEUTICS COM Call 27,400 -81.97 122 -79.93 n/a n/a n/a
2022-02-11 2021-12-31 13F ALDEYRA THERAPEUTICS COM Call 152,000 -16.99 608 -62.19 n/a n/a n/a
2021-11-12 2021-09-30 13F ALDEYRA THERAPEUTICS COM Call 183,100 80.75 1,608 40.07 n/a n/a n/a
2021-08-10 2021-06-30 13F ALDEYRA THERAPEUTICS COM Call 101,300 303.59 1,148 285.23 n/a n/a n/a
2021-05-12 2021-03-31 13F ALDEYRA THERAPEUTICS COM Call 25,100 638.24 298 1,195.65 n/a n/a n/a
2021-02-10 2020-12-31 13F ALDEYRA THERAPEUTICS COM Call 3,400 -58.02 23 -61.67 n/a n/a n/a
2020-11-12 2020-09-30 13F ALDEYRA THERAPEUTICS COM Call 8,100 -79.75 60 -64.07 n/a n/a n/a
2020-08-13 2020-06-30 13F ALDEYRA THERAPEUTICS COM Call 40,000 393.83 167 178.33 n/a n/a n/a
2020-02-10 2019-12-31 13F ALDEYRA THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-12 2019-09-30 13F ALDEYRA THERAPEUTICS COM Call 1,100 -54.17 6 -57.14 n/a n/a n/a
2019-08-09 2019-06-30 13F ALDEYRA THERAPEUTICS COM Call 2,400 -87.10 14 -91.67 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ALDEYRA THERAPEUTICS COM Call 18,600 500.00 168 546.15 n/a n/a n/a
2019-05-13 2019-03-31 13F ALDEYRA THERAPEUTICS COM Call 18,600 168 n/a n/a n/a
2019-02-05 2018-12-31 13F ALDEYRA THERAPEUTICS COM Call 3,100 -75.78 26 -85.31 n/a n/a n/a
2018-11-08 2018-09-30 13F ALDEYRA THERAPEUTICS COM Call 12,800 141.51 177 321.43 n/a n/a n/a
2018-08-13 2018-06-30 13F ALDEYRA THERAPEUTICS COM Call 5,300 -31.17 42 -27.59 n/a n/a n/a
2018-05-16 2018-03-31 13F/A ALDEYRA THERAPEUTICS COM Call 7,700 58 n/a n/a n/a
2018-05-10 2018-03-31 13F ALDEYRA THERAPEUTICS COM Call 7,700 58 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F ALDEYRA THERAPEUTICS COM Put 128,400 497.21 665 493.75 n/a n/a n/a
2025-11-12 2025-09-30 13F ALDEYRA THERAPEUTICS COM Put 21,500 220.90 112 348.00 n/a n/a n/a
2025-08-14 2025-06-30 13F ALDEYRA THERAPEUTICS COM Put 6,700 -95.75 26 -97.24 n/a n/a n/a
2025-05-14 2025-03-31 13F ALDEYRA THERAPEUTICS COM Put 157,800 -21.88 907 -9.93 n/a n/a n/a
2025-05-14 2024-12-31 13F/A ALDEYRA THERAPEUTICS COM Put 202,000 639.93 1,008 585.03 n/a n/a n/a
2025-02-14 2024-12-31 13F ALDEYRA THERAPEUTICS COM Put 202,000 1,008 n/a n/a n/a
2024-11-14 2024-09-30 13F ALDEYRA THERAPEUTICS COM Put 27,300 313.64 147 600.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ALDEYRA THERAPEUTICS COM Put 6,600 -46.34 22 -47.50 n/a n/a n/a
2024-05-10 2024-03-31 13F ALDEYRA THERAPEUTICS COM Put 12,300 23.00 40 14.29 n/a n/a n/a
2024-02-14 2023-12-31 13F ALDEYRA THERAPEUTICS COM Put 10,000 -51.92 35 -74.64 n/a n/a n/a
2023-11-09 2023-09-30 13F ALDEYRA THERAPEUTICS COM Put 20,800 -47.74 139 -58.56 n/a n/a n/a
2023-08-09 2023-06-30 13F ALDEYRA THERAPEUTICS COM Put 39,800 -63.18 334 -68.97 n/a n/a n/a
2023-05-12 2023-03-31 13F ALDEYRA THERAPEUTICS COM Put 108,100 34.96 1,073 92.64 n/a n/a n/a
2023-02-09 2022-12-31 13F ALDEYRA THERAPEUTICS COM Put 80,100 80,000.00 557 55,600.00 n/a n/a n/a
2022-11-09 2022-09-30 13F ALDEYRA THERAPEUTICS COM Put 100 -94.12 1 -85.71 n/a n/a n/a
2022-08-11 2022-06-30 13F ALDEYRA THERAPEUTICS COM Put 1,700 -98.33 7 -98.45 n/a n/a n/a
2022-05-12 2022-03-31 13F ALDEYRA THERAPEUTICS COM Put 101,800 -20.22 453 -11.18 n/a n/a n/a
2022-02-11 2021-12-31 13F ALDEYRA THERAPEUTICS COM Put 127,600 283.18 510 74.66 n/a n/a n/a
2021-11-12 2021-09-30 13F ALDEYRA THERAPEUTICS COM Put 33,300 179.83 292 116.30 n/a n/a n/a
2021-08-10 2021-06-30 13F ALDEYRA THERAPEUTICS COM Put 11,900 138.00 135 128.81 n/a n/a n/a
2021-05-12 2021-03-31 13F ALDEYRA THERAPEUTICS COM Put 5,000 100.00 59 247.06 n/a n/a n/a
2021-02-10 2020-12-31 13F ALDEYRA THERAPEUTICS COM Put 2,500 78.57 17 70.00 n/a n/a n/a
2020-11-12 2020-09-30 13F ALDEYRA THERAPEUTICS COM Put 1,400 -44.00 10 -41.18 n/a n/a n/a
2020-05-12 2020-03-31 13F ALDEYRA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F ALDEYRA THERAPEUTICS COM Put 9,400 -44.38 55 -38.20 n/a n/a n/a
2019-11-12 2019-09-30 13F ALDEYRA THERAPEUTICS COM Put 16,900 76.04 89 53.45 n/a n/a n/a
2019-08-09 2019-06-30 13F ALDEYRA THERAPEUTICS COM Put 9,600 -82.39 58 -88.21 n/a n/a n/a
2019-05-14 2019-03-31 13F/A ALDEYRA THERAPEUTICS COM Put 54,500 467.71 492 748.28 n/a n/a n/a
2019-05-13 2019-03-31 13F ALDEYRA THERAPEUTICS COM Put 54,500 492 n/a n/a n/a
2019-02-05 2018-12-31 13F ALDEYRA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F ALDEYRA THERAPEUTICS COM Put 1,200 17 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.